To further explore the role of CASP4 in regulating tumor immunotherapy, we investigated the association between the expression of CASP4 and immunomodulators such as immune checkpoint molecules, chemokines, and chemokine receptors using GEPIA2. This evidence concerns the gene CASP4 and neoplasm.